Stay updated with breaking news from Anoop Misra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Semaglutide, the mega-seller diabetes and weight-loss drug, can significantly reduce the risk of side effects such as kidney failure, heart attacks, and death in patients with type 2 diabetes and kidney disease, according to a study published in the New England Journal of Medicine (NEJM).
A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis, characterized by delayed stomach emptying. The study, presented at Digestive Disease Week 2024, indicates a 30% higher risk for users of these drugs. Experts emphasize the need for awareness and medical monitoring of potential gastrointestinal side effects.
India News: A new US study suggests that weight-loss medications like Wegovy and Ozempic may have rare but serious side effects, including abdominal paralysis, li
Experts noted that curbing air pollution levels is one of the most important modifiable risk factors for preventing new onset of diabetes cases.
Reducing air pollution levels in India can be the key to curb the rising burden of diabetes in the country, health experts said on Thursday.